San-Juan D, Mejía-Cornejo JJ, Coronas-Bustos G, Vázquez GR, Hernández-Ruiz A, Canela-Calderón OJ

Language: Spanish
References: 16
Page: 217-220
PDF size: 141.63 Kb.

ABSTRACT

Of the various complications of infectious meningoencephalitis, Guillain-Barre syndrome is rare. We report the case of a woman 37 years old, who begins with infectious meningoencephalitis and after 9 days a worsening of the strength and sensitivity of all four extremities was observed. Clinical suspicion and electromyography lead us to diagnose axonal demyelinating polyneuropathy of all four extremities. We didn’t identified any causative agent. The integral management and inmunomodulator (IgG IV 0.4g/kg/dx5d) was based on the principles established for the two neurological conditions observed in the patient. The patient recovered successfully at 6 months of follow-up.

REFERENCES

1. Centers for disease control and prevention. Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity- United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:761-4.

2. Benenson Abram S. Organización Panamericana de la Salud. Manual para el control de las enfermedades transmisibles. Washington, D.C. 1997.

3. Puri V, Khalil A, Suri V. Guillain-Barré syndrome following meningococcal meningitis. Postgrad Med J 1995;71:42-3.

4. Banfi AP. Encefalitis: ¿cuáles y cómo tratar? Rev Child Infect 2003,20:28-33.

5. Boos J, Esiri MM. Influenza virus, enteroviruses, and other epidemic viruses. En Boos J, Esiri MM, editor. Viral encephalitis in humans. Washington, D.C.: ASM Press 2003;143-62.

6. Komatsu H, Kuroki S, Shimizu Y, Takada H, Takeuchi Y. Mycoplasma pneumoniae infection, meningoencephalitis, and cerebellitis with antiganglioside antibodies. Pediatr Neurol 1998;18:160-4.

7. Christie LJ, Honarmand S, Yagi S, Ruiz S, Glaser CA. Antigalactocerebroside testing in Mycoplasma pneumoniaeassociated encephalitis. J Neuroimmunol 2007;189:129-31.

8. Sinha S, Prasad KN, Jain D, Pandey CM, Jha S, Pradhan S. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barreì syndrome: a single centre prospective case-control study. Clin Microbiol Infect 2007;13:334-7.

9. Tsugawa T, Nikaido K, Doi T, Koga M, Susuki K, Kubota T, et al. Guillain-Barre syndrome with meningoencephalitis after Campylobacter jejuni infection. Pediatr Infect Dis J 2004; 23:966-8.

10. Hanzawa F, Fuchigami T, Ishii W, Nakajima S, Kawamura Y, Endo A, et al. A 3-year-old boy with Guillain-Barré syndrome and encephalitis associated with Mycoplasma pneumoniae infection. J Infect Chemother 2014;20:134-8.

11. Benedetti L, Franciotta D, Beronio A, Delucchi S, Capellini C, Sette MD. Meningoencephalitis-like onset of post-infectious AQP4-IgG-positive optic neuritis complicated by GM1-IgGpositive acute polyneuropathy. Mult Scler 2014 [in press]

12. Van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Communityacquired bacterial meningitis in adults. N Engl J Med 2006;354:44-53.

13. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294-304.

14. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, et al. Enteroviral meningitis: natural histor y and outcome of pleconaril therapy. Antimicrob Agents Chemother 2006;50:2409-14.

15. Zhong M, Cai F. Current perspectives on Guillain Barré Syndrome. World J Pediatr 2007;3:187-94.

16. Casas I, Palacios GF, Trallero G, Cisterna D, Freire MC, Tenorio A. Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J Med Virol 2001;65:138-48.